General Information of Drug (ID: DMCUNZL)

Drug Name
E2023
Synonyms Lorcaserin
Indication
Disease Entry ICD 11 Status REF
Dravet syndrome 8A61.11 Phase 3 [1]
Drug Type
Small molecule
Cross-matching ID
TTD ID
D3SJB9

References

1 ClinicalTrials.gov (NCT04572243) A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome. U.S.National Institutes of Health.